Boulos Zacharie

1.3k total citations
45 papers, 876 citations indexed

About

Boulos Zacharie is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Boulos Zacharie has authored 45 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 15 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Boulos Zacharie's work include Synthesis and Characterization of Heterocyclic Compounds (8 papers), Chemical Synthesis and Reactions (8 papers) and HIV/AIDS drug development and treatment (6 papers). Boulos Zacharie is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (8 papers), Chemical Synthesis and Reactions (8 papers) and HIV/AIDS drug development and treatment (6 papers). Boulos Zacharie collaborates with scholars based in Canada and United States. Boulos Zacharie's co-authors include James D. Wuest, Christopher Penney, Gilles Sauvé, Lyne Gagnon, André L. Beauchamp, Timothy P. Connolly, Marc J. Olivier, Nghe Nguyen‐Ba, Laval Chan and Giorgio Attardo and has published in prestigious journals such as Journal of the American Chemical Society, Circulation and Blood.

In The Last Decade

Boulos Zacharie

44 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boulos Zacharie Canada 17 601 253 164 114 90 45 876
Ante Nagl Croatia 16 583 1.0× 217 0.9× 127 0.8× 71 0.6× 58 0.6× 80 836
Andrew E. Derome United Kingdom 17 514 0.9× 437 1.7× 153 0.9× 103 0.9× 39 0.4× 39 941
J. V. N. Vara Prasad United States 22 826 1.4× 415 1.6× 103 0.6× 77 0.7× 205 2.3× 50 1.2k
Klaus‐Jürgen Schaper Germany 18 458 0.8× 289 1.1× 95 0.6× 138 1.2× 70 0.8× 43 950
Mladen Mintas Croatia 21 903 1.5× 394 1.6× 91 0.6× 194 1.7× 123 1.4× 86 1.4k
Paolo Strazzolini Italy 17 613 1.0× 282 1.1× 178 1.1× 75 0.7× 47 0.5× 65 904
Patrick McCarren United States 17 508 0.8× 539 2.1× 92 0.6× 76 0.7× 70 0.8× 23 1.0k
I. Fonseca Spain 18 643 1.1× 241 1.0× 148 0.9× 62 0.5× 24 0.3× 69 1.0k
Andrzej E. Wróblewski Poland 19 884 1.5× 270 1.1× 187 1.1× 58 0.5× 89 1.0× 89 1.1k
Jacques Uziel France 20 899 1.5× 435 1.7× 176 1.1× 72 0.6× 59 0.7× 51 1.1k

Countries citing papers authored by Boulos Zacharie

Since Specialization
Citations

This map shows the geographic impact of Boulos Zacharie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boulos Zacharie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boulos Zacharie more than expected).

Fields of papers citing papers by Boulos Zacharie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boulos Zacharie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boulos Zacharie. The network helps show where Boulos Zacharie may publish in the future.

Co-authorship network of co-authors of Boulos Zacharie

This figure shows the co-authorship network connecting the top 25 collaborators of Boulos Zacharie. A scholar is included among the top collaborators of Boulos Zacharie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boulos Zacharie. Boulos Zacharie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laurin, Pierre, et al.. (2016). Abstract 19469: PBI-4050 Reduces Cardiovascular Biomarkers in Type II Diabetic Patients With Metabolic Syndrome. Circulation. 2 indexed citations
2.
Zacharie, Boulos, et al.. (2011). A Facile Synthesis of 6H-[1,3,5]Triazino[2,1-b]quinazolin-6-ones. Synthesis. 2011(11). 1733–1740.
3.
Perron, Valérie, et al.. (2009). Synthesis and antimicrobial activity of 2-fluorophenyl-4,6-disubstituted [1,3,5]triazines. Bioorganic & Medicinal Chemistry Letters. 20(3). 945–949. 57 indexed citations
4.
Zacharie, Boulos, Abdallah Ezzitouni, Jean‐Simon Duceppe, & Christopher Penney. (2009). A Simple and Efficient Large-Scale Synthesis of Metal Salts of Medium-Chain Fatty Acids. Organic Process Research & Development. 13(3). 581–583. 2 indexed citations
5.
Perron, Valérie, et al.. (2009). ChemInform Abstract: A Method for the Selective Protection of Aromatic Amines in the Presence of Aliphatic Amines.. ChemInform. 40(22). 2 indexed citations
6.
Zacharie, Boulos, et al.. (2008). A Method for the Selective Protection of Aromatic Amines in the Presence of Aliphatic Amines. Synthesis. 2009(2). 283–289. 6 indexed citations
7.
Zacharie, Boulos, et al.. (2008). 2,6,9-Trisubstituted purine derivatives as protein A mimetics for the treatment of autoimmune diseases. Bioorganic & Medicinal Chemistry Letters. 19(1). 242–246. 5 indexed citations
8.
Zacharie, Boulos, et al.. (2007). Enhancement of Th1 type cytokine production and primary T cell activation by PBI-1393. Clinical Immunology. 125(3). 318–327. 6 indexed citations
9.
Jennings, Harold J., et al.. (2001). Immunostimulant oxidized β-glucan conjugates. International Immunopharmacology. 1(3). 539–550. 31 indexed citations
10.
Zacharie, Boulos, et al.. (2001). A Mild Procedure for the Reduction of Pyridine N-Oxides to Piperidines Using Ammonium Formate. The Journal of Organic Chemistry. 66(15). 5264–5265. 38 indexed citations
11.
Nguyen‐Ba, Nghe, et al.. (2000). Synthesis of N-1-oxypyrimidine 1,3-dioxolane and 1,3-oxathiolane nucleosides. Chemical Communications. 2311–2312. 2 indexed citations
12.
Zacharie, Boulos, et al.. (2000). Synergistic anti-tumor activity of a novel immunomodulator, BCH-1393, in combination with cyclophosphamide. International Journal of Immunopharmacology. 22(9). 659–671. 13 indexed citations
13.
Gagnon, Lyne, et al.. (2000). d-LysAsnProTyr tetrapeptide: a novel B-cell stimulant and stabilized bursin mimetic. Vaccine. 18(18). 1886–1892. 7 indexed citations
14.
Nguyen‐Ba, Nghe, et al.. (2000). Synthesis and antiviral activities of N-9-oxypurine 1,3-Dioxolane and 1,3-oxathiolane nucleosides. Bioorganic & Medicinal Chemistry Letters. 10(19). 2223–2226. 15 indexed citations
16.
Zacharie, Boulos, Timothy P. Connolly, & Christopher Penney. (1995). A Simple One-Step Conversion of Carboxylic Acids to Esters Using EEDQ. The Journal of Organic Chemistry. 60(21). 7072–7074. 35 indexed citations
17.
Humber, David C., Martin F. Jones, Boulos Zacharie, et al.. (1992). Expeditious preparation of (−)-2′-deoxy-3′-thiacytidine (3TC). Tetrahedron Letters. 33(32). 4625–4628. 40 indexed citations
19.
Beauchamp, André L., Marc J. Olivier, James D. Wuest, & Boulos Zacharie. (1986). Multidentate Lewis acids. Crystal structure of the 2:1 adduct of 1,2-phenylenedimercury dichloride with tetraphenylphosphonium chloride. Journal of the American Chemical Society. 108(1). 73–77. 48 indexed citations
20.
Zacharie, Boulos, et al.. (1985). Structure of tetraphenylphosphonium triiodomercurate(II), [P(C6H5)4][HgI3]. Acta Crystallographica Section C Crystal Structure Communications. 41(3). 369–371. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026